GSK Vaccine Virtual Days is returning for a 4th edition on 29th & 30th March 2023. This virtual event will bring together healthcare professionals and experts from the international vaccine community to discuss and present important updates, data, and trends in adult immunisation.
As highlighted during the COVID-19 pandemic, prevention of infectious diseases in adults has become an international public health priority. Vaccine Virtual Days 2023 will connect healthcare professionals to learn about and reflect on the opportunities, challenges and the future of adult immunisation.
Your opportunity to connect with the global vaccine community and hear the latest insights on adult immunisation
The Vaccine Virtual Days event will provide data, insights, and updates on a number of key topics relevant for Physicians/Specialists, Nurses, Pharmacists, NITAGs, Medical Societies, and others in the international vaccine community:
Physicians/Specialists
As the global population ages, the overall burden of infectious diseases in older adults is increasing. Don’t miss your opportunity to learn how to improve patient awareness of the benefits of adult immunisation and much more!
Nurses
Despite the benefits of vaccination, rates of adult immunisation remain low in many countries. Don’t miss your opportunity to learn from experts about the importance of engaging with patients throughout their healthcare journey, supporting the complex and varied needs of at-risk populations.
Pharmacists
Your role in providing information around disease prevention and administering vaccination services has never been more important. Vaccine Virtual Days 2023 will feature discussions from global vaccine experts on the increasing role that pharmacists play in disease prevention and global health.
NITAGs/Medical Societies
The pandemic outbreaks emphasised the value of prevention and preparedness ahead of any future pandemics or public health threats. At Vaccine Virtual Days 2023 you will hear discussions centred on the need for stronger vaccination policies to improve adult immunisation rates.
The agenda topics have been selected by a Scientific Committee of international experts including:
Jane Barratt
Lulu C. Bravo
Javier Díez-Domingo
Stefan Gravenstein
Stefania Maggi
Justin Ortiz
Usa Thisyakorn
Thomas Weinke
Submit your questions HERE for the "Ask the experts" session hosted by the Scientific Committee
CLICK HERE to view information from the previous edition of Vaccine Virtual Days, which included attendees from over 135 countries, who learned about the value and importance of adult immunisation
Let science lead every day – We look forward to seeing you there!
Material supplied by the above-country business unit to LOCs for localisation must be subject to local Medical and/or Regulatory review and approval prior to use and/or external distribution.
LOCs to insert local adverse events reporting procedure.
© 2023 GSK group of companies or its licensor. All rights reserved. GlaxoSmithKline Biologicals SA, Rixensart, Belgium.
NX-GBL-GVX-WCNT-220027 | January 2023